Page 91 - 2018 Powerlist

Dr Yvonne Greenstreet and insight would help to “realise our mission of building Science, Medicine & Engineering
Executive Vice-President, Alnylam a top-tier biopharmaceutical company founded on RNAi
and speed the path of bringing potentially life-changing
Pharmaceuticals
new therapies to patients through innovative drug
development, commercial, and patient access strategies”.
One of the most influential people in global Dr Greenstreet has responsibility for leading the
pharmaceuticals, Dr Greenstreet was appointed company’s multi-disciplinary product teams from early
to the senior leadership team of the Philadelphia development through and during commercialisation.
biopharmaceutical giant Alnylam last September. She said: “I’m thrilled to be part of a team pioneering
The company hired her to help push plans for rapid new medicines to meet unmet needs for patients. This
growth in the market, based on the groundbreaking RNAi is a vitally important mission where I believe I can add
technology – the process of so-called ‘gene silencing’ to significant value.” Dr Greenstreet serves as an adviser
combat cancer and other diseases. and board member for several public companies and also
Announcing her appointment, Alnylam CEO, John serves on the Scientific Advisory Committee for the Bill
Maraganore, said he was confident that her experience and Melinda Gates Foundation.

powerful-media.com 87